International Symposium on Psychiatric Genetics and Epigenetics
ISPGE
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track will explore the latest findings in genetic research related to various psychiatric disorders. Emphasis will be placed on identifying specific genetic markers and their implications for diagnosis and treatment.
SDG 3
SDG 4
This session will focus on the role of epigenetics in shaping mental health outcomes. Discussions will include how environmental factors can influence gene expression and contribute to psychiatric conditions.
SDG 3
SDG 4
This track will highlight innovative neuroscience methodologies used to investigate psychiatric disorders. It aims to bridge the gap between basic neuroscience and clinical applications in psychiatry.
SDG 3
SDG 9
This session will delve into cognitive processes and their relationship with psychiatric conditions. Presentations will cover cognitive assessments and interventions that can enhance mental health.
SDG 3
SDG 4
This track will examine evidence-based behavioral health interventions for psychiatric disorders. The focus will be on integrating behavioral approaches with traditional psychiatric treatments.
SDG 3
SDG 4
This session will discuss the practical implications of genetic findings in clinical psychiatry. Topics will include personalized medicine and the ethical considerations of genetic testing.
SDG 3
SDG 4
This track will explore the interplay between emotional wellbeing and psychiatric health. Presentations will focus on interventions aimed at enhancing emotional resilience.
SDG 3
SDG 4
This session will investigate the neurobiological factors associated with various psychiatric conditions. Emphasis will be placed on brain imaging studies and their contributions to understanding psychiatric illnesses.
SDG 3
SDG 4
This track will highlight the importance of translational research in bridging the gap between genetic discoveries and clinical practice. Discussions will focus on how genetic insights can inform therapeutic strategies.
SDG 3
SDG 9
This session will address the genetic and epigenetic factors contributing to psychiatric comorbidities. Presentations will explore the complexities of diagnosing and treating co-occurring disorders.
SDG 3
SDG 4
This track will provide a forward-looking perspective on emerging trends and technologies in psychiatric genetics and epigenetics. Discussions will include potential breakthroughs and their implications for future research and clinical practice.
SDG 3
SDG 9